SCHEMBL4029952

SCHEMBL4029952

CCCN(c1cc(C(=O)O)cc(Cl)n1)S(C)(=O)=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 2/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
CA12 O43570 1/20 0.38
CA2 P00918 1/20 0.38
RAB9A P51151 1/20 0.38
CA9 Q16790 1/20 0.38
SLC22A6 Q4U2R8 1/20 0.38
SLC22A8 Q8TCC7 1/20 0.38
ABCC2 Q92887 1/20 0.38
SLC22A12 Q96S37 1/20 0.38
UGT1A7 Q9HAW7 1/20 0.38
SLC22A11 Q9NSA0 1/20 0.38
HCAR3 P49019 4/20 0.37
RXRA P19793 1/20 0.36
KMT2A Q03164 1/20 0.35
CTRC Q99895 1/20 0.34
TTR P02766 1/20 0.33
ALDH1A1 P00352 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
TPMT P51580 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1816292 0.86 ALDH1A1 (0.40) BACE1SMN1; SMN2RAB9AKMT2AALDH1A1
SCHEMBL1813973 0.80 PSEN1 (0.35) BACE1ALDH1A1NPSR1ESR1
SCHEMBL2021183 0.79 TTR (0.38) BACE1SMN1; SMN2KMT2ACTRCTTR
SCHEMBL1812360 0.77 BACE1 (0.35) BACE1ALDH1A1NPSR1
SCHEMBL11677713 0.75 KMT2A (0.51) SMN1; SMN2RAB9AHCAR3KMT2ACTRC
SCHEMBL3349338 0.75 HCAR3 (0.43) HCAR3RXRACTRCTTRALDH1A1
SCHEMBL2814523 0.74 TTR (0.39) SMN1; SMN2HCAR3KMT2ACTRCTTR
SCHEMBL15295913 0.74 TTR (0.39) SMN1; SMN2RAB9AHCAR3KMT2ACTRC
SCHEMBL898570 0.73 TTR (0.44) SMN1; SMN2CA12CA2CA9KMT2A
SCHEMBL16142630 0.72 HCAR3 (0.34) CA12HCAR3RXRACTRCTTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1689713-A4 BENZYLETHER AND BENZYLAMINO BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER S DISEASE MERCK & CO INC (US) 2009-02-18 EP disclosed
EP-1689713-A1 BENZYLETHER AND BENZYLAMINO BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER S DISEASE Merck & Co., Inc. (US) 2006-08-16 EP disclosed
WO-2005051914-A1 BENZYLETHER AND BENZYLAMINO BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK & CO., INC. (US) 2005-06-09 WO disclosed